Abiraterone acetate plus LHRH therapy versus abiraterone acetate while sparing LHRH therapy in patients with progressive, metastatic and chemotherapy-naïve, castration-resistant prostate cancer (SPARE): study protocol for a randomized controlled trial

Ohlmann, Carsten-Henning; Jäschke, Michelle; Jaehnig, Peter; Krege, Susane; Gschwend, Jürgen; Rexer, Heidrun; Stöckle, Michael

doi:10.1186/s13063-017-2195-x

Trials

Article metrics
Last updated: Thu, 25 Apr 2024 7:47:11 Z

Abiraterone acetate plus LHRH therapy versus abiraterone acetate while sparing LHRH therapy in patients with progressive, metastatic and chemotherapy-naïve, castration-resistant prostate cancer (SPARE): study protocol for a randomized controlled trial

Access & Citations

2623

Article Accesses
8

Web of Science
9

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1745-6215

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com